{"title":"CEC01-02 Chemical Respiratory Allergy: Identification of true chemical respiratory allergens","authors":"J. Arts","doi":"10.1016/j.toxlet.2025.07.012","DOIUrl":null,"url":null,"abstract":"<div><div><em>See Pemberton et al. (2024)</em>: Asthma in the workplace (work-related asthma) is an important occupational health issue. It comprises two main subtypes: viz. pre-existing asthma which is exacerbated by work (work-exacerbated asthma or WEA) or asthma caused by work (occupational asthma or OA). The latter can be subdivided in non-allergic irritant-induced occupational asthma (IIOA) and in allergic occupational asthma (AOA). AOA may be fatal.</div><div>Current regulatory paradigms for the management of OA are not fit for purpose. For both effective human health protection and appropriate and proportionate regulation there is an important, yet unmet need, that sub-types of work-related asthma can be accurately identified and classified, and that chemical respiratory allergens that drive allergic asthma can be differentiated according to potency.</div><div>In my presentation I will address presently available strategies for the diagnosis and characterisation of asthma in the workplace, such as human health studies, clinical investigations and experimental approaches (structure-activity relationships, assessments of chemical reactivity, experimental animal studies and <em>in vitro</em> methods). Each of these approaches has limitations with respect to providing a clear discrimination between WEA and OA, and between AOA and IIOA. Against this background the need for improved characterisation of work-related asthma, in the context of more appropriate regulation is discussed.</div></div>","PeriodicalId":23206,"journal":{"name":"Toxicology letters","volume":"411 ","pages":"Page S5"},"PeriodicalIF":2.9000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378427425015942","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
See Pemberton et al. (2024): Asthma in the workplace (work-related asthma) is an important occupational health issue. It comprises two main subtypes: viz. pre-existing asthma which is exacerbated by work (work-exacerbated asthma or WEA) or asthma caused by work (occupational asthma or OA). The latter can be subdivided in non-allergic irritant-induced occupational asthma (IIOA) and in allergic occupational asthma (AOA). AOA may be fatal.
Current regulatory paradigms for the management of OA are not fit for purpose. For both effective human health protection and appropriate and proportionate regulation there is an important, yet unmet need, that sub-types of work-related asthma can be accurately identified and classified, and that chemical respiratory allergens that drive allergic asthma can be differentiated according to potency.
In my presentation I will address presently available strategies for the diagnosis and characterisation of asthma in the workplace, such as human health studies, clinical investigations and experimental approaches (structure-activity relationships, assessments of chemical reactivity, experimental animal studies and in vitro methods). Each of these approaches has limitations with respect to providing a clear discrimination between WEA and OA, and between AOA and IIOA. Against this background the need for improved characterisation of work-related asthma, in the context of more appropriate regulation is discussed.
参见Pemberton et al.(2024):工作场所哮喘(与工作相关的哮喘)是一个重要的职业健康问题。它包括两种主要亚型:即因工作而加重的已有哮喘(工作加重哮喘或WEA)或由工作引起的哮喘(职业性哮喘或OA)。后者可细分为非过敏性刺激物诱发的职业性哮喘(IIOA)和过敏性职业性哮喘(AOA)。AOA可能是致命的。目前管理OA的监管模式不适合这一目的。为了有效地保护人类健康和适当和适当的调节,有一个重要但尚未得到满足的需求,即能够准确地识别和分类与工作有关的哮喘亚型,并且能够根据效力区分导致过敏性哮喘的化学呼吸道过敏原。在我的演讲中,我将讨论目前可用的工作场所哮喘诊断和表征策略,如人类健康研究、临床调查和实验方法(构效关系、化学反应性评估、实验动物研究和体外方法)。这些方法在提供WEA和OA之间以及AOA和IIOA之间的明确区分方面都有局限性。在此背景下,需要改善工作相关哮喘的特征,在更适当的监管的背景下进行讨论。